Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program
Publication
, Conference
Allen, LA; Felker, GM; Pocock, SJ; McMurray, JJV; Pfeffer, MA; Swedberg, K; Wang, D; Yusuf, S; Michelson, EL; Granger, CB
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
March 6, 2007
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
March 6, 2007
Volume
49
Issue
9
Start / End Page
44A / 44A
Location
New Orleans, LA
Publisher
ELSEVIER SCIENCE INC
Conference Name
56th Annual Scientific Session of the American-College-of-Cardiology
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Allen, L. A., Felker, G. M., Pocock, S. J., McMurray, J. J. V., Pfeffer, M. A., Swedberg, K., … Granger, C. B. (2007). Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 49, pp. 44A-44A). New Orleans, LA: ELSEVIER SCIENCE INC.
Allen, Larry A., G Michael Felker, Stuart J. Pocock, John J. V. McMurray, Marc A. Pfeffer, Karl Swedberg, Duolao Wang, Salim Yusuf, Eric L. Michelson, and Christopher B. Granger. “Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 49:44A-44A. ELSEVIER SCIENCE INC, 2007.
Allen LA, Felker GM, Pocock SJ, McMurray JJV, Pfeffer MA, Swedberg K, et al. Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2007. p. 44A-44A.
Allen, Larry A., et al. “Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 49, no. 9, ELSEVIER SCIENCE INC, 2007, pp. 44A-44A.
Allen LA, Felker GM, Pocock SJ, McMurray JJV, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2007. p. 44A-44A.
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
March 6, 2007
Volume
49
Issue
9
Start / End Page
44A / 44A
Location
New Orleans, LA
Publisher
ELSEVIER SCIENCE INC
Conference Name
56th Annual Scientific Session of the American-College-of-Cardiology
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology